Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha-5 (ITGA5) is a cell surface receptor protein encoded by the ITGA5 gene, belonging to the integrin alpha chain family. Integrins are transmembrane heterodimeric proteins composed of alpha and beta subunits; integrin alpha-5 primarily pairs with beta-1 (ITGB1) to form the fibronectin receptor (also known as very late activation protein 5, VLA-5)[2][4]. This complex recognizes RGD-motif ligands such as fibronectin and fibrinogen, mediating cell–extracellular matrix adhesion and intracellular signaling events. ITGA5 regulates essential functions including cell migration, proliferation, differentiation (notably in bone and adipose tissues), and angiogenesis, and is implicated in various pathologies including cancer progression, cardiovascular remodeling, and infectious disease mechanisms[1][3][4]. High ITGA5 expression correlates with tumor invasiveness and poor prognosis in certain cancers[1][4]. Therapeutically, ITGA5 is being investigated as a drug target for conditions ranging from cancer to tissue repair, but clinical translation faces challenges due to roles in normal tissue functions and potential safety concerns.
Inhibition of integrin–ligand binding (blocking RGD-motif ligand recognition, e.g., fibronectin, fibrinogen), Interference with adhesion signaling, Modulation of cell migration and survival
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha-5 (ITGA5).